Purchase Order 75N93023P01284
- Not listed
- Becton, Dickinson and Company, doing business as BD, has been awarded a $20,504.50 firm fixed price purchase order contract by the Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide BD Biosciences reagents. The place of performance will be BD's facility in Franklin Lakes, New Jersey. The contract period of performance spans from September 14, 2023 through December 29, 2023. No major subcontractors or set aside...
- Becton, Dickinson and Company, doing business as BD, has been awarded a $21,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide Whole Transcriptome Analysis amplification reagent kits. The reagent kits will support NIAID's research efforts under the description provided in the original solicitation. Performance will take place in Franklin Lakes, New Jersey over a four month period concluding at the end of...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Purchase Order to Becton, Dickinson And Company, operating through its BD Diagnostic Systems division, to provide 35 BD Antibodies. The award, which did not utilize a set-aside designation, has a potential value of $8,442.60 and a completion date of January 24, 2019. Becton, Dickinson And Company is a major medical technology manufacturer that...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $25,072.00 firm fixed price purchase order contract to Becton, Dickinson And Company (BD) for BD reagents to support vaccine research. The contract does not have a set-aside designation and is scheduled for completion on February 24, 2023. BD is a global medical technology company that provides instruments, reagents, and services for biomedical research and...
- This federal contract award is for ANTIBODIES AND BIOLOGICALS, issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the prime contractor Becton, Dickinson and Company (BD). The $4,514.60 firm fixed-price purchase order does not have a set-aside designation. BD is a global medical technology company that provides a range of medical supplies, instruments, and diagnostic products, including flow cytometry and cell...
- This firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD) for $24,138.00. The contract is for the delivery of unspecified products or services related to BD's Biosciences division, which provides instruments, reagents, and services that support biomedical research and clinical applications through flow cytometry, cell imaging, and genomics...
- This is a $6,532 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Becton, Dickinson and Company (BD). The contract is not set aside for any particular business category. BD is a global medical technology company that provides instruments, reagents, and services supporting biomedical research and clinical applications, including through flow cytometry, cell imaging, and genomics...
- The National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), awarded a $54,930.70 firm fixed-price purchase order to Becton, Dickinson and Company (BD) for the procurement of 64 specific BD Biosciences brand conjugated antibodies and laboratory reagents. The contract, which has no set-aside designation, was issued through a Request for Quotes (RFQ-NIAID-25-2258428) under the Simplified Acquisition Procedures of the Federal Acquisition...
- Becton, Dickinson and Company (BD) has been awarded a firm fixed price purchase order valued at fifteen thousand dollars by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. This award is for pre-contract inspection services to support the BD FACSymphony A5 cell analyzer, to be performed in Bethesda, Maryland. No set-aside designation was used for this procurement. BD Biosciences, a division of BD, will provide the required inspection services...
- The National Institute of Allergy and Infectious Diseases awarded a purchase order to Becton, Dickinson and Company (BD Biosciences division) valued at $497,331.25 on August 13, 2018, for maintenance of BD equipment. Performance is located in Franklin Lakes, New Jersey. The order covers maintenance services for BD-manufactured biomedical research instruments and diagnostic equipment. The ultimate completion date is September 14, 2018. Pricing is firm fixed price with no small business...
Becton, Dickinson and Company, doing business as BD, has been awarded a purchase order contract valued at approximately $13,924.50 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases. Under the terms of the contract, BD will provide BD Antibodies (AMBIS #2187100) to support NIH/NIAID's research efforts related to allergies and infectious diseases. Place of performance will be BD's facilities in Franklin Lakes, New Jersey, with work expected to be completed by October 31, 2023. No subcontractors or set-aside designations were identified. This purchase order award is consistent with NIH/NIAID's mission to conduct and support research on the causes, treatments, and cures for infectious and immune-mediated diseases.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.9k | 9/13/23 |